Understanding SCGB1A1: A Potential Drug Target for Cancer (G7356)

Target Name: SCGB1A1

NCBI ID: G7356

SCGB1A1

Understanding SCGB1A1: A Potential Drug Target for Cancer

SCGB1A1 (short for short-form core gene for beta-glucan 1 alpha-1) is a protein that is expressed in various tissues throughout the body, including the liver, pancreas, and muscle. It is a type of cytoskeleton protein that is involved in the structure and function of cells, and is composed of two main subunits: a long alpha-helix and a short beta-sheet.

The protein encoded by SCGB1A1 is involved in a variety of cellular processes, including cell adhesion, migration, and invasion. It is also involved in the regulation of cell growth, and has been shown to play a role in the development and progression of several diseases , including cancer.

SCGB1A1 has also been identified as a potential drug target, due to its involvement in cellular processes that are often disrupted in cancer cells. For example, studies have shown that SCGB1A1 is highly expressed in various types of cancer, and that inhibiting its activity can lead to the growth arrest and apoptosis of cancer cells.

In addition to its potential as a drug target, SCGB1A1 also has potential as a biomarker for cancer diagnosis and treatment. For example, studies have shown that the expression of SCGB1A1 is often elevated in the blood and other tissues of people with various types of cancer , making it a potential biomarker for cancer diagnosis.

Furthermore, some studies have shown that SCGB1A1 can be used as a target for small molecules, which may be used to inhibit its activity in cancer cells. This highlights the potential of SCGB1A1 as a drug or biomarker for cancer treatment.

In conclusion, SCGB1A1 is a protein that is involved in a variety of cellular processes and has been shown to play a role in the development and progression of cancer. Its potential as a drug target and biomarker make it an attractive target for research into the treatment of cancer. Further studies are needed to fully understand its role and potential as a drug or biomarker.

Protein Name: Secretoglobin Family 1A Member 1

Functions: Binds phosphatidylcholine, phosphatidylinositol, polychlorinated biphenyls (PCB) and weakly progesterone, potent inhibitor of phospholipase A2

The "SCGB1A1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SCGB1A1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets